Innovative Dual Antibody Therapy for Difficult-to-Treat Multiple Myeloma Patients This article explores the recently submitted dual antibody therapy using Tarvey® and Tecvayli® for treating relapsed or refractory multiple myeloma with extramedullary disease.

Innovative Dual Antibody Therapy for Difficult-to-Treat Multiple Myeloma Patients #Japan #Tokyo #Multiple_Myeloma #TECVAYLI #Tarvey